Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC has successfully completed a fundraising initiative, securing £6.42 million through the issuance of 7,129,615 new Ordinary Shares, which includes a retail offer that contributed £0.16 million. The retail offer was conducted at an issue price of 90 pence per share, and the new shares are anticipated to begin trading on AIM on 9 August 2024. Director Christine Soden participated in the transaction, which was deemed fair and reasonable by the company’s independent director after consultation with the nominated adviser, Panmure Liberum.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
